Luther King Capital Management (LKCM) Portfolio holdings
AUM
$23B
1-Year Return
15.96%
This Quarter Return
+5.25%
1 Year Return
+15.96%
3 Year Return
+72.77%
5 Year Return
+138.1%
10 Year Return
+369.43%
AUM
$13.7B
AUM Growth
+$630M
(+4.8%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
550
New
33
Increased
180
Reduced
167
Closed
24
Top Buys
| 1 |
Charles River Laboratories
CRL
|
+$31.3M |
| 2 |
Air Products & Chemicals
APD
|
+$23.3M |
| 3 |
Oracle
ORCL
|
+$21.9M |
| 4 |
Corteva
CTVA
|
+$21.4M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$19.3M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$53.7M |
| 2 |
AbbVie
ABBV
|
+$36.1M |
| 3 |
DuPont de Nemours
DD
|
+$28.3M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$18.8M |
| 5 |
Emerson Electric
EMR
|
+$18.3M |
Sector Composition
| 1 | Technology | 18.5% |
| 2 | Healthcare | 16.29% |
| 3 | Financials | 14.99% |
| 4 | Industrials | 13.58% |
| 5 | Consumer Discretionary | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Southwest Airlines
LUV
$16.7B
| $850K | 0.01% |
16,741
+3,106
| +23% | +$158K |
|
352
S&P Global
SPGI
$167B
| $837K | 0.01% |
+3,673
| New | +$837K |
|
353
Cerus
CERS
$249M
| $808K | 0.01% |
143,690
-49,955
| -26% | -$281K |
|
354
Phillips 66
PSX
$52.6B
| $793K | 0.01% |
8,479
+1,083
| +15% | +$101K |
|
355
Kroger
KR
$45B
| $790K | 0.01% |
36,400
-63
| -0.2% | -$1.37K |
|
356
Boston Scientific
BSX
$160B
| $786K | 0.01% |
18,296
-21,466
| -54% | -$922K |
|
357
Garmin
GRMN
$46.1B
| $769K | 0.01% |
9,641
+205
| +2% | +$16.4K |
|
358
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| – | – |
0
| – | -$757K |
|
359
Exact Sciences
EXAS
$10.2B
| $745K | 0.01% |
6,310
| – | – |
|
360
HEICO
HEI
$44.2B
| $743K | 0.01% |
5,555
-3,580
| -39% | -$479K |
|
361
PotlatchDeltic
PCH
$3.3B
| $743K | 0.01% |
19,059
| – | – |
|
362
Gentex
GNTX
$6.3B
| $712K | 0.01% |
28,950
-3,450
| -11% | -$84.9K |
|
|
PFPT
363
DELISTED
Proofpoint, Inc.
PFPT
| $694K | 0.01% |
5,770
| – | – |
|
364
Novartis
NVS
$249B
| $670K | ﹤0.01% |
7,338
+3,102
| +73% | +$283K |
|
|
ZIXI
365
DELISTED
Zix Corporation
ZIXI
| $654K | ﹤0.01% |
72,000
-7,000
| -9% | -$63.6K |
|
366
Marsh & McLennan
MMC
$100B
| $649K | ﹤0.01% |
6,510
| – | – |
|
|
BCOV
367
DELISTED
Brightcove, Inc.
BCOV
| $646K | ﹤0.01% |
62,500
+7,500
| +14% | +$77.5K |
|
368
Vanguard Intermediate-Term Bond ETF
BIV
$24.3B
| – | – |
0
| – | -$522K |
|
369
Graco
GGG
$14.2B
| $628K | ﹤0.01% |
12,505
-6,110
| -33% | -$307K |
|
370
W.W. Grainger
GWW
$47.7B
| $626K | ﹤0.01% |
2,335
| – | – |
|
371
Gilead Sciences
GILD
$144B
| $620K | ﹤0.01% |
9,181
+660
| +8% | +$44.6K |
|
372
A10 Networks
ATEN
$1.27B
| $614K | ﹤0.01% |
90,000
+15,000
| +20% | +$102K |
|
373
Watsco
WSO
$16.6B
| $606K | ﹤0.01% |
3,705
+1,515
| +69% | +$248K |
|
374
iShares MSCI Germany ETF
EWG
$2.53B
| – | – |
0
| – | -$607K |
|
375
SEI Investments
SEIC
$10.8B
| $601K | ﹤0.01% |
10,708
-15,004
| -58% | -$842K |
|